-
May 21, 2013
Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
-
May 03, 2013
Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
-
February 15, 2013
Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2013 earnings per American Depositary Share (ADS) of 40 ...
-
February 14, 2013
Mylan (MYL) extended its three-year old partnership with India-based Biocon Limited. The companies recently signed a ...
-
February 12, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that it has enrolled the first patient in the phase IV ...
-
February 12, 2013
Perrigo Company (PRGO) recently announced that it is set to acquire a UK-based privately held pharmaceutical ...
-
February 11, 2013
Lannett Company, Inc. (LCI) reported second quarter fiscal 2013 earnings of 10 cents per share, above the Zacks ...
-
February 08, 2013
Supernus Pharmaceuticals, Inc. (SUPN) recently provided information on its agreement with Patheon Inc. (PNHNF) for ...
-
February 08, 2013
Recently, Warner Chilcott plc (WCRX) received encouraging news when the US Food and Drug Administration (FDA) ...
-
February 08, 2013
Teva Pharmaceutical Industries (TEVA) reported fourth quarter earnings of $1.32 per American Depositary Share (ADS), ...
-
February 04, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently terminated its collaboration with CureTech Ltd. for the ...
-
January 31, 2013
Actavis, Inc. (ACT), formerly known as Watson Pharmaceuticals, Inc., recently provided an update on its 2012 ...
-
January 30, 2013
Santarus, Inc. (SNTS) recently filed a patent infringement lawsuit against Mylan, Inc. (MYL) which is looking to ...
-
January 30, 2013
Merck & Co. Inc. (MRK) is scheduled to report its fourth quarter 2012 results on Feb 1, 2013 before the opening ...
-
January 30, 2013
Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
Pfizer Inc. (PFE) posted fourth quarter earnings of 47 cents per share, 3 cents above the Zacks Consensus Estimate ...
-
January 29, 2013
We expect Perrigo Company (PRGO) to beat expectations when it releases its second quarter fiscal 2013 results ...
-
January 24, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced disappointing top-line results from a study evaluating ...
